GSE188570 GSE188571 decitabine 5 v 1 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE188570_GSE188571_decitabine_5_v_1_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE188570_GSE188571_decitabine_5_v_1_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE188570_GSE188571_decitabine_5_v_1_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE188570_GSE188571_decitabine_5_v_1_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

small nucleolar RNA host gene 19

Gene

LSP1 pseudogene 5

Gene

chromosome 10 putative open reading frame 55

Gene

uncharacterized LOC400627

Gene

MPHOSPH10 pseudogene 3

Gene

importin 8 pseudogene 1

Gene

ribosomal protein L23 pseudogene 2

Gene

CXXC finger protein 1 pseudogene 1

Gene

MIS18A antisense RNA 1

Gene

RNA, 7SL, cytoplasmic 423, pseudogene

  • Gene

    small nucleolar RNA host gene 19


  • Gene

    LSP1 pseudogene 5


  • Gene

    chromosome 10 putative open reading frame 55


  • Gene

    uncharacterized LOC400627


  • Gene

    MPHOSPH10 pseudogene 3


  • Gene

    importin 8 pseudogene 1


  • Gene

    ribosomal protein L23 pseudogene 2


  • Gene

    CXXC finger protein 1 pseudogene 1


  • Gene

    MIS18A antisense RNA 1


  • Gene

    RNA, 7SL, cytoplasmic 423, pseudogene

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.